# Study of Bleeding With Extended Administration of an Oral Contraceptive

> **NCT00338052** · PHASE2 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 207 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Norethindrone 1 mg / ethinyl estradiol 20 mcg

## Key facts

- **NCT ID:** NCT00338052
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2008-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00338052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00338052, "Study of Bleeding With Extended Administration of an Oral Contraceptive". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00338052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*